Stocks and Investing
Stocks and Investing
Tue, September 13, 2022
[ Tue, Sep 13th 2022
] - WOPRAI
[ Tue, Sep 13th 2022
] - WOPRAI
[ Tue, Sep 13th 2022
] - WOPRAI
[ Tue, Sep 13th 2022
] - WOPRAI
[ Tue, Sep 13th 2022
] - WOPRAI
[ Tue, Sep 13th 2022
] - WOPRAI
[ Tue, Sep 13th 2022
] - WOPRAI
[ Tue, Sep 13th 2022
] - WOPRAI
[ Tue, Sep 13th 2022
] - WOPRAI
[ Tue, Sep 13th 2022
] - WOPRAI
[ Tue, Sep 13th 2022
] - WOPRAI
[ Tue, Sep 13th 2022
] - WOPRAI
[ Tue, Sep 13th 2022
] - WOPRAI
Mon, September 12, 2022
[ Mon, Sep 12th 2022
] - WOPRAI
[ Mon, Sep 12th 2022
] - WOPRAI
[ Mon, Sep 12th 2022
] - WOPRAI
[ Mon, Sep 12th 2022
] - WOPRAI
[ Mon, Sep 12th 2022
] - WOPRAI
[ Mon, Sep 12th 2022
] - WOPRAI
[ Mon, Sep 12th 2022
] - WOPRAI
[ Mon, Sep 12th 2022
] - WOPRAI
[ Mon, Sep 12th 2022
] - WOPRAI
[ Mon, Sep 12th 2022
] - WOPRAI
[ Mon, Sep 12th 2022
] - WOPRAI
[ Mon, Sep 12th 2022
] - WOPRAI
[ Mon, Sep 12th 2022
] - WOPRAI
[ Mon, Sep 12th 2022
] - WOPRAI
[ Mon, Sep 12th 2022
] - WOPRAI
[ Mon, Sep 12th 2022
] - WOPRAI
Jeffrey Hung Maintained (CELU) at Hold with Decreased Target to $50 on, Sep 12th, 2022
Jeffrey Hung of Morgan Stanley, Maintained "Celularity Inc." (CELU) at Hold with Decreased Target from $80 to $50 on, Sep 12th, 2022.
Jeffrey has made no other calls on CELU in the last 4 months.
There are 3 other peers that have a rating on CELU. Out of the 3 peers that are also analyzing CELU, 1 agrees with Jeffrey's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Asthika Goonewardene of "Truist Securities" Maintained at Hold with Decreased Target to $60 on, Tuesday, August 23rd, 2022
These are the ratings of the 2 analyists that currently disagree with Jeffrey
- James Molloy of "Alliance Global Partners" Initiated at Strong Buy and Held Target at $150 on, Thursday, August 25th, 2022
- Swayampakula Ramakanth of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $150 on, Wednesday, June 22nd, 2022
Contributing Sources